Gemini Pharmaceuticals Inc., a global contract manufacturer of specialty pharmaceuticals, over-the-counter (OTC) pharmaceuticals, and dietary and nutritional supplements for the past 30 years, announces the appointment of Mark Jost as the new senior vice president of business development.

Mark was most recently senior vice president of corporate development at ChromaDex Inc. During his time at ChromDex, he was responsible for the management of the analytical laboratory in Boulder, Colo., the ComplyID program, and the operational side of the BluScience product line as well as performing various business development and sales roles. 

Prior to joining ChromDex, Mark held executive positions at SION Power, NSF International, and Eagle Picher Industries. While at NSF International, he was one of the founders of their dietary supplement program.

Commenting on his new role, Mark stated, “This is an exciting opportunity to work for one of the premier contract manufacturing organizations in the US. Gemini understands what is needed for cGMP compliance and works diligently with its partners to insure they are fully compliant with the regulations. Gemini provides clear, concise batch documentation that enables their partners to quickly understand the quality systems and procedures Gemini employs when making their products.”

Mike Finamore, CEO of Gemini Pharmaceutical, commented, "It is with great pride and enthusiasm that I welcome Mark as a member of the Gemini team.  His tremendous insight and experience in the dietary supplement industry will be a great asset to our business development efforts."